Publications by authors named "Todd A Triplett"

Claim this Profile
S
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics.
Nadia Siles Alvarado, Maisey Schuler, Cole Maguire, Dzifa A Amengor, Annalee W Nguyen, Todd A Triplett

Commun Med (Lond)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics.
Nadia Siles, Maisey Schuler, Cole Maguire, Dzifa Amengor, Annalee Nguyen, Todd A Triplett

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors.
Anna R Schreiber, Jodi A Kagihara, Bradley R Corr, S Lindsey Davis, Christopher Lieu, Todd A Triplett

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy.
Nisha Holay, Alexander Somma, Mark Duchow, Milad Soleimani, Anna Capasso, Todd A Triplett

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.
Kristin G Anderson, David A Braun, Aitziber Buqué, Sarah B Gitto, Jennifer L Guerriero, Todd A Triplett

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy.
Sam A Bazzi, Cole Maguire, Nisha Holay, Janelle Geltman, Kerin Hurley, Todd A Triplett

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglia depletion and alcohol: Transcriptome and behavioral profiles.
Anna S Warden, Todd A Triplett, Aram Lyu, Emily K Grantham, Moatasem M Azzam

Addict Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated myeloid cells provide critical support for T-ALL.
Aram Lyu, Todd A Triplett, Seo Hee Nam, Zicheng Hu, Dhivya Arasappan

Blood· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer.
Meghan J Bloom, Angela M Jarrett, Todd A Triplett, Anum K Syed, Tessa Davis

BMC Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms.
Mihailo Miljanic, Anna Capasso, Todd A Triplett, S Gail Eckhardt, Kyaw L Aung

J Immunother Precis Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.
Todd A Triplett, Kendra C Garrison, Nicholas Marshall, Moses Donkor, John Blazeck

Nat Biotechnol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous dendritic cells from the tumor microenvironment support T-ALL growth via IGF1R activation.
Todd A Triplett, Kim T Cardenas, Jessica N Lancaster, Zicheng Hu, Hilary J Selden

Proc Natl Acad Sci U S A· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade.
Todd A Triplett, Christopher G Tucker, Kendra C Triplett, Zefora Alderman, Lihong Sun

Cancer Immunol Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG.
Todd A Triplett, Brendan D Curti, Peter R Bonafede, William L Miller, Edwin B Walker

Eur J Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis